RankingsPricing
  1. US-listed companies
  2. MEDICINOVA INC
  3. Financials
  4. Cash and cash equivalents

MEDICINOVA INCMNOV

Market cap
$72.1M
P/E ratio
SummaryFinancials
Period EndCash and cash equivalents (Million USD)YoY (%)
Dec 31, 202440-20.86%
Dec 31, 202351+175.59%
Dec 31, 202219-74.09%
Dec 31, 202171+18.98%
Dec 31, 202060-5.89%
Dec 31, 201964+2.37%
Dec 31, 201862+122.61%
Dec 31, 201728+16.06%
Dec 31, 201624+9.25%
Dec 31, 201522+89.18%
Dec 31, 201412+74.16%
Dec 31, 20137+67.07%
Dec 31, 20124-73.43%
Dec 31, 201115

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)